Voyager Therapeutics Inc (VYGR)
7.50
-0.05
(-0.66%)
USD |
NASDAQ |
Apr 19, 16:00
7.50
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Total Assets (Quarterly): 351.28M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 351.28M |
September 30, 2023 | 294.65M |
June 30, 2023 | 315.54M |
March 31, 2023 | 336.29M |
December 31, 2022 | 159.36M |
September 30, 2022 | 182.48M |
June 30, 2022 | 188.60M |
March 31, 2022 | 224.18M |
December 31, 2021 | 193.86M |
September 30, 2021 | 184.77M |
June 30, 2021 | 208.73M |
March 31, 2021 | 237.72M |
December 31, 2020 | 261.58M |
September 30, 2020 | 269.76M |
June 30, 2020 | 297.46M |
March 31, 2020 | 322.61M |
December 31, 2019 | 354.76M |
September 30, 2019 | 376.22M |
Date | Value |
---|---|
June 30, 2019 | 388.59M |
March 31, 2019 | 411.35M |
December 31, 2018 | 177.03M |
September 30, 2018 | 197.06M |
June 30, 2018 | 214.66M |
March 31, 2018 | 235.03M |
December 31, 2017 | 184.48M |
September 30, 2017 | 140.92M |
June 30, 2017 | 158.41M |
March 31, 2017 | 175.09M |
December 31, 2016 | 189.57M |
September 30, 2016 | 201.98M |
June 30, 2016 | 209.82M |
March 31, 2016 | 219.98M |
December 31, 2015 | 229.46M |
September 30, 2015 | 166.44M |
June 30, 2015 | 173.76M |
December 31, 2014 | 11.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
159.36M
Minimum
Dec 2022
388.59M
Maximum
Jun 2019
270.97M
Average
269.76M
Median
Sep 2020
Total Assets (Quarterly) Benchmarks
Biogen Inc | 26.84B |
United Therapeutics Corp | 7.167B |
MEI Pharma Inc | 78.54M |
Macrogenics Inc | 298.42M |
Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 114.96M |
Shareholders Equity (Quarterly) | 236.32M |
Current Ratio | 4.956 |